other material
confidence high
sentiment neutral
materiality 0.70
Apellis enters $300M at-the-market equity offering with Jefferies LLC
Apellis Pharmaceuticals, Inc.
- Apellis may sell up to $300M common stock in at-the-market offerings through Jefferies LLC.
- Jefferies receives commission of up to 3% of gross proceeds for acting as sales agent.
- Prior $150M equity distribution agreement with Citigroup and Jefferies terminated.
- Shares sold under existing automatic shelf registration statement effective Jan 2020.